Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIPHON: Pitavastatin Safety and Efficacy in Hyperlipidemic Patients with IFG
NCT02056847Phase 4Completed
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Sep 2013
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pitavastatin in hyperlipidemia, sponsored by JW Pharmaceutical Corporation. Started Sep 2013; status: completed.
02
Drugs
pitavastatin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT02056847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02056847.